Response to Reduced Diurnal Variation of Heart Rate Is Associated With Increased Plasma B‐Type Natriuretic Peptide Level in Patients With Atrial Fibrillation

Kamikawa S et al. Clin Cardiol. 2013;36:394–400
Source: Clinical Cardiology - Category: Cardiology Authors: Tags: Letters to the Editor Source Type: research

Related Links:

Being in a dry environment, such as on a plane, can cause dehydration and heart issues. According to Mellanie True Hills, CEO of StopAfib.org, a patient advocacy organization that hosts the number one arrhythmia site and one of the top five heart disease sites worldwide, “The significantly dry air on a plane wicks moisture out of the body, causing dehydration quickly. Dehydration thickens the blood and depletes the body of essential minerals such as potassium and magnesium. Magnesium regulates the heart rhythm and potassium helps it work. Inadequate levels of potassium or magnesium can trigger abnormal heart rhythms,...
Source: Embrace Your Heart Wellness Initiative - Category: Cardiology Authors: Tags: Diet and Nutrition Tips Heart Health Source Type: blogs
The health tracking market is booming. What with smart bracelets, smart beds and smart chest straps, the tracking industry has penetrated the lives of old and young from the time they wake up in the morning to the time they hit the bed at night (and beyond). It’s no wonder that user penetration is projected to reach 25% of the adult population by 2022 in the US alone and that these devices are being adopted by over 30% of individuals across all age groups. Naturally, I count among those adopters. I call myself a data geek, using the data accumulated from myriads of health trackers to help me make more informed hea...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Health Sensors & Trackers digital health digital technology health data digital health sensors Source Type: blogs
AbstractLedwoch and colleagues demonstrated in their article entitled “Impact of transcatheter mitral valve repair using MitraClip on right ventricular remodeling” that right ventricular function improved in most of the patients following MitraClip implantation whereas 20% of them experienced worsening of right ventricular function which associated with worse prog nosis, despite the latter cohort achieved comparable improvement in the mitral regurgitation. Given most of the latter cohort had atrial fibrillation, aggressive catheter ablation to improve atrial fibrillation before or after MitraClip implantation m...
Source: The International Journal of Cardiovascular Imaging - Category: Radiology Source Type: research
This study investigated the role and involvement of NaV1.8 (SCN10A) in arrhythmia generation in the human atria and in mice lacking NaV1.8. NaV1.8 mRNA and protein were detected in human atrial myocardium at a significant higher level compared to ventricular myocardium. Expression of NaV1.8 and NaV1.5 did not differ between myocardium from patients with atrial fibrillation and sinus rhythm. To determine the electrophysiological role of NaV1.8, we investigated isolated human atrial cardiomyocytes from patients with sinus rhythm stimulated with isoproterenol. Inhibition of NaV1.8 by A-803467 or PF-01247324 showed no effects ...
Source: Basic Research in Cardiology - Category: Cardiology Source Type: research
AbstractOral anticoagulation options for patients with venous thromboembolism (VTE) include vitamin K antagonists like warfarin. Good warfarin control is linked to outcomes of therapy, and the SAMe –TT2R2 model has been reported to predict control in atrial fibrillation patients with scores  ≥ 2 linked to poor control. There has been limited and conflicting data in VTE populations, therefore this study aimed at determining the predictive ability of this model in Australian patients with deep vein thrombosis. Retrospective data of patients receiving warfarin care at a private path ology clinic in Quee...
Source: Journal of Thrombosis and Thrombolysis - Category: Hematology Source Type: research
In the current issue of the International Journal of Cardiology, the article by Rizvi et al. adds significant evidence to the current body of knowledge regarding the pathophysiological mechanisms involved in post cardiac surgery new onset atrial fibrillation (PoAF) [1]. The incidence [2], predictive factors [3] and prognostic value of this PoAF have been thoroughly studied, but no randomized study has managed to obtain a decrease in incidence or an improvement in prognosis. Moreover, it is still unclear whether PoAF should be treated as an epiphenomenon linked to the acute setting and cardiac injury, or as the first sympto...
Source: International Journal of Cardiology - Category: Cardiology Authors: Tags: Editorial Source Type: research
Publication date: Available online 19 February 2020Source: Canadian Journal of CardiologyAuthor(s): Hsin-Fu Lee, Yi-Hsin Chan, Pei-Ru Li, Jia-Rou Liu, Tze-Fan Chao, Lung-Sheng Wu, Shang-Hung Chang, Yung-Hsin Yeh, Chi-Tai Kuo, Lai-Chu See, Gregory Y.H. LipAbstractBackgroundEvidences of clinical outcomes for oral anticoagulants and antiplatelet treatment (APT) in atrial fibrillation (AF) patients with critical limb ischemia (CLI) are very limited.MethodsIn this nationwide retrospective cohort study collected from Taiwan National Health Insurance Research Database, 1,223 AF patients with CLI taking DOACs, warfarin, or APT wer...
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
ConclusionIn the presented report, in patients with nonvalvular atrial fibrillation the LAmbre offered similar long ‐term efficacy and safety in comparison to Amplatzer devices.This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - Category: Cardiology Authors: Tags: ORIGINAL ARTICLE Source Type: research
Authors: Grubb A, Mentz RJ Abstract Introduction: Both heart failure with reduced ejection fraction (HFrEF) and atrial fibrillation (AF) independently cause significant morbidity and mortality. Moreover, the two conditions commonly coexist and AF in the setting of HFrEF is associated with worse all-cause mortality, hospitalizations, and quality of life compared to HFrEF without AF. Despite the large burden of these conditions, there is no clear optimal clinical management strategy for when they occur together.Areas Covered: This review focuses on the pharmacological management of AF in HFrEF. Studies were identifie...
Source: Expert Review of Cardiovascular Therapy - Category: Cardiology Tags: Expert Rev Cardiovasc Ther Source Type: research
Condition:   Atrial Fibrillation, Myocardial Infarction Intervention:   Drug: non-systematic prescription of anticoagulant therapy Sponsor:   Centre Hospitalier de PAU Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Atrial Fibrillation | Cardiology | Heart